Aryl sulfonic acids and derivatives as fsh antagonists

This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently,...

Full description

Saved in:
Bibliographic Details
Main Authors JAMES WINFIELD JETTER, JOHN FRANCIS ROGERS, WENLING KAO, JAY EDWARD WROBEL, DANIEL MICHAEL GREEN
Format Patent
LanguageEnglish
Published 16.10.2000
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently, hydrogen, OR , -S(O)mR , -NHR , -N(R )2, or -CH2SO2CH3; R and R are each, independently, hydrogen, -NO2, -NH2, -SO2R , or -CH2R ; R is hydrogen, C1 to C6 alkyl, C3 to C6 alkenyl, -CH2CH2Z, -CH2COR , -CH2CH=CHCOR , (e), (f) or (g); Y1 and Y are each, independently, N, or CH; Y and Y are each independently, O, S, or NR ; R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; Z is -OR8, -OCH2CH2OR , -N(R )2, or (h); R8 is hydrogen or C1 to C3 alkyl; R is C1 to C6 alkyl, C3 to C6 alkenyl, OH, NHR , N(R )2, CH2COR , -CH2CH=CHCOR , or (i); R is C1 to C3 alkyl, C3 to C4 alkenyl, phenyl, -CH2CH2OCH3, or -(j); R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; R is hydrogen, or C1 to C3 alkyl; R is hydrogen, or C1 to C3 alkyl; W is a bond, CH2, CH2CH2, O, S(O)q, NCHO, NCOCH3, or NR ; m is 0 - 2; n is 0 - 2; q is 0 - 2, with the proviso that R and R are not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
AbstractList This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently, hydrogen, OR , -S(O)mR , -NHR , -N(R )2, or -CH2SO2CH3; R and R are each, independently, hydrogen, -NO2, -NH2, -SO2R , or -CH2R ; R is hydrogen, C1 to C6 alkyl, C3 to C6 alkenyl, -CH2CH2Z, -CH2COR , -CH2CH=CHCOR , (e), (f) or (g); Y1 and Y are each, independently, N, or CH; Y and Y are each independently, O, S, or NR ; R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; Z is -OR8, -OCH2CH2OR , -N(R )2, or (h); R8 is hydrogen or C1 to C3 alkyl; R is C1 to C6 alkyl, C3 to C6 alkenyl, OH, NHR , N(R )2, CH2COR , -CH2CH=CHCOR , or (i); R is C1 to C3 alkyl, C3 to C4 alkenyl, phenyl, -CH2CH2OCH3, or -(j); R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; R is hydrogen, or C1 to C3 alkyl; R is hydrogen, or C1 to C3 alkyl; W is a bond, CH2, CH2CH2, O, S(O)q, NCHO, NCOCH3, or NR ; m is 0 - 2; n is 0 - 2; q is 0 - 2, with the proviso that R and R are not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
Author DANIEL MICHAEL GREEN
JOHN FRANCIS ROGERS
JAY EDWARD WROBEL
JAMES WINFIELD JETTER
WENLING KAO
Author_xml – fullname: JAMES WINFIELD JETTER
– fullname: JOHN FRANCIS ROGERS
– fullname: WENLING KAO
– fullname: JAY EDWARD WROBEL
– fullname: DANIEL MICHAEL GREEN
BookMark eNrjYmDJy89L5WQwcyyqzFEoLs1Jy8_LTFZITM5MKVZIzEtRSEktyixLLMksSwXyixXSijOAwiWJ6UBlxSXFPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3jHUxMDE1MLAwNGYsAoA5qYugw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID AU4045800A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU4045800A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:56:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU4045800A3
Notes Application Number: AU20000040458
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001016&DB=EPODOC&CC=AU&NR=4045800A
ParticipantIDs epo_espacenet_AU4045800A
PublicationCentury 2000
PublicationDate 20001016
PublicationDateYYYYMMDD 2000-10-16
PublicationDate_xml – month: 10
  year: 2000
  text: 20001016
  day: 16
PublicationDecade 2000
PublicationYear 2000
RelatedCompanies AMERICAN HOME PRODUCTS CORPORATION
RelatedCompanies_xml – name: AMERICAN HOME PRODUCTS CORPORATION
Score 2.5227134
Snippet This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Aryl sulfonic acids and derivatives as fsh antagonists
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001016&DB=EPODOC&locale=&CC=AU&NR=4045800A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LSwMxEB5qFfWmVanvHGRvi7Hd52GR7T4oQh9IK72VpNmlhbItzVbx3zsJXfXSWx4wTJKZZJKZ-QLwxH3KfFx3081bjmm5jJuel7VMlCUno0x4vv7urdd3umPrbWJPajCvcmE0TuiXBkdEjZqhvpd6v17_PWLFOrZSPvMFNq1e01EQG9XtWCOmGXEnSIaDeBAZUYQ3SaP_HljKIUhpeACHaES7SheSj47KSVn_P1DSMzgaIq2iPIdaVjTgJKr-XWvAcW_n7sbiTvPkBTjh5ntJ5HaZKyxbwmYLIQkrBBEoQp8avRvrkuRyjs3K1aQgceUlPKbJKOqayMD0d6zTcFxx2r6CerEqsiaQmcNZnouc21RYXNgctxnKvReLobllC_samvuo3OzvuoVTnVeuwjOcO6iXm212jydsyR_05PwAau2AnA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf7MHsbXHCNsbDYmAfQYVBzDC8Le26BRIyCB0a_3uvDVNfeOtHcrm2d-21d_crwAPt6qSL6651spalGR1CNdtOWxrKkpXqhNld-d3bKLQGU-N1Zs4qMC9zYSRO6JcER0SNSlDfC7lfr_8esTwZW8kf6QKbVs9B5HhqeTuWiGmq13f8ydgbu6rr4k1SDd8dQzgEdb13AIdoYHeELvgffZGTsv5_oASncDRBWnlxBpU0r0PNLf9dq8PxaOfuxuJO8_g5WL3N91Lh22UmsGwVkiwYV0jOFIYi9CnRu7HOlYzPsVm4mgQkLr-AZuBH7kBDBuLfsca9aclp-xKq-SpPG6AkFiVZxjJq6sygzKS4zejUfjIImlsmM6-gsY_K9f6uJtQG0WgYD1_Ctxs4kTnmIlTDuoVqsdmmd3jaFvReTtQPnnKDjw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Aryl+sulfonic+acids+and+derivatives+as+fsh+antagonists&rft.inventor=JAMES+WINFIELD+JETTER&rft.inventor=JOHN+FRANCIS+ROGERS&rft.inventor=WENLING+KAO&rft.inventor=JAY+EDWARD+WROBEL&rft.inventor=DANIEL+MICHAEL+GREEN&rft.date=2000-10-16&rft.externalDBID=A&rft.externalDocID=AU4045800A